82,411 Followers on Owler

GSK

GlaxoSmithKline discovers, develops and manufactures medicines, vaccines and consumer healthcare products. Read more

Dame Emma Walmsley's photo - CEO of GSK

CEO

Dame Emma Walmsley

CEO Approval Rating

73/100

Founded:

2000

Status:

PublicIndependent CompanyLondon Stock ExchangeGSK

GSK TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

BMS is perceived as one of GSK's biggest rivals. BMS was founded in 1858 in New York, New York. BMS is in the Pharmaceuticals field. BMS generates $3.5B less revenue than GSK.

Johnson & Johnson is GSK's #2 rival. Johnson & Johnson is a Public company that was founded in 1886 in New Brunswick, New Jersey. Johnson & Johnson competes in the Health Care Supplies industry. Compared to GSK, Johnson & Johnson has 40,934 more employees.

Merck is one of GSK's top competitors. Merck's headquarters is in Kenilworth, New Jersey, and was founded in 1891. Like GSK, Merck also operates in the Pharmaceuticals industry. Merck generates 103% of GSK's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Roche a competitor of GSK?

GSK Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$46.3B

GSK's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 30.9B. Over the last three quarters, GSK's revenue has grown by 54.6%. Specifically, in Q4 2020's revenue was $14.5B; in Q3 2020, it was $11.1B; in Q2 2020, it was $9.4B.

GSK Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Sitari Pharmaceuticals

Sep 2019

Source »
undisclosed
-
TESARO, Inc.

Dec 2018

Source »
$5.1B
TESARO is a biopharmaceutical company that identifies, acquires, develops and commercializes cancer therapeutics.

-

Global Vaccines Business, Novartis AG

Mar 2015

Source »
$5.3B
-
Glycovaxyn AG

Feb 2015

Source »
$190M
GlycoVaxyn discovers, develops and manufactures next-generation bioconjugate vaccines.
Okairos Srl

May 2013

Source »
$325M
-

These are all the companies that GSK has acquired. GSK has acquired 10 companies and its latest acquisition was Sitari Pharmaceuticals in Sep 2019.

GSK Funding History

No recent funding data found related to GSK

GSK Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Adrestia Therapeutics is a biotechnology company that develops precision medicines to treat rare diseases.
-
Dec 17, 2020
Series A
-
CureVac is a biopharmaceutical company that develops and commercializes mRNA-based therapies for the treatment of cancer and infectious diseases.
$164.3M
Jul 19, 2020
Corporate Round
Aug 12, 2020
Save the Children is a non-profit organization that provides education and employment opportunities for economically backward children.
$1.5M
Jun 07, 2019
Grant
-
SpringWorks develops and commercializes clinical drug therapies for the treatment of cancer, oncology and rare genetic diseases.
$125M
Mar 31, 2019
Series B
Sep 13, 2019
Sitryx develops immunometabolic therapies for the treatment of cancer and autoimmune diseases.
$30M
Oct 07, 2018
Series A
-

These are all the companies that GSK has invested in. GSK has invested 10 companies and its latest investment was Sitari Pharmaceuticals in Sep 2019.

GSK News

June 14, 2021MarketScreener

Material Event (Form 6-K)

(marketscreener.com) 14 June 2021, London UK & Gosselies Belgium GSK and iTeos Therapeutics announce ... See more »
June 14, 2021Pharmabiz

GSK, iTeos Therapeutics ink agreement to codevelop & commercialise antiTIGIT monoclonal antibody, EOS448

GlaxoSmithKline plc (GSK) and iTeos Therapeutics (ITOS) announced an agreement to co─develop and co─c... See more »
June 14, 2021KamCity

GSK's Consumer Healthcare Unit Planning Brand Acquisitions After Separation

GSK's Consumer Healthcare unit will be looking to make deals in growth areas such as vitamins once it... See more »
June 14, 2021BioSpace

GSK Inks Potential $1.4 Billion Oncology Deal With Belgium-Based iTeos

Shares of iTeos Therapeutics skyrocketed more than 50% in premarket trading after it struck an agreem... See more »
June 9, 2021Reuters

REUTERS EVENTS GSK consumer arm confident that growth, cash flow will help with debt

Strong cash flow and growth will enable GlaxoSmithKline's (GSK.L) consumer products business to cope ... See more »

GSK Press Releases

December 3, 2020PR Newswire

TUMS Helps America Put 2020 To Bed Early This New Year's Eve

WARREN, N.J., Dec. 3, 2020 /PRNewswire/ -- As America's #1 heartburn medicine, TUMS® knows millions o... See more »
December 1, 2020PR Newswire Asia

Bora Pharmaceuticals completes acquisition of former GSK facility

MISSISSAUGA, ON, Dec. 1, 2020 /PRNewswire/ -- Bora Pharmaceuticals Co., Ltd announced today that the ... See more »
November 16, 2020GlobeNewswire

Exagen and GSK partner for 4th straight year, driving greater awareness of challenges facing lupus diagnosis and management

SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to ... See more »
November 13, 2020Cision Canada

GSK named one of Canada's Top 100 Employers in the year of the pandemic

/CNW/ - GSK has been named as one of Canada's Top 100 Employers for 2021. This award, the second cons... See more »
September 8, 2020PR Newswire

New Advil Dual Action with Acetaminophen

WARREN, N.J., Sept. 8, 2020 /PRNewswire/ -- GSK Consumer Healthcare (LSE/NYSE: GSK) today announced t... See more »
August 6, 2020Business Wire

Seattle Genetics Achieves Milestone Payment Under Antibody-Drug Conjugate Collaboration with GlaxoSmithKline Triggered by BLENREP (belantamab mafodotin-blmf) FDA Approval

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced U.S. Food and D... See more »

GSK Videos

Social Media

GSK Headquarters

980 Great West Road Brentford

Middlesex, EnglandTW8 9GS

44-20-8047-5000

Driving Directions »

Trending Companies

GSK Summary

ABOUT

Overview

GlaxoSmithKline plc (LSE: GSK; NYSE: GSK) discovers, develops, manufactures pharmaceuticals, vaccines, and consumer health products. GSK is a British pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo W...

CEO

GSK's CEO, Dame Emma Walmsley, currently has an approval rating of 73%. GSK's primary competitors are BMS, Johnson & Johnson & Merck.

Website

gsk.com

Frequently Asked Questions about GSK

  1. When was GSK founded?

    GSK was founded in 2000
  2. Who is GSK's CEO?

    GSK's CEO is Dame Emma Walmsley
  3. How much revenue does GSK generate?

    GSK generates $46.3B in revenue
  4. How much funding does GSK have?

    GSK has historically raised $0 in funding
  5. Where is GSK's headquarters?

    GSK's headquarters is in Middlesex England, GB
  1. How many employees does GSK have?

    GSK has 94,066 employees
  2. What sector does GSK operate in?

    GSK is in Pharmaceuticals
  3. Who are GSK's competitors?

    GSK's top competitors are BMS, Johnson & Johnson, Merck
  4. Who has GSK invested in?

    GSK's has invested in companies such as Adrestia, CureVac, Save the Children